a developer of specialty pharmaceuticals
Industry Biotechnology
A.I.dvisor tells us that ACHV and GLYC have been poorly correlated (+33% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that ACHV and GLYC's prices will move in lockstep.
Ticker / NAME | Correlation To ACHV | 1D Price Change % | ||
---|---|---|---|---|
ACHV | 100% | -2.93% | ||
GLYC - ACHV | 33% Poorly correlated | +3.50% | ||
CDTX - ACHV | 30% Poorly correlated | -1.01% | ||
SNPX - ACHV | 28% Poorly correlated | +10.50% | ||
AVRO - ACHV | 27% Poorly correlated | -1.28% | ||
ARRY - ACHV | 27% Poorly correlated | +1.96% | ||
More |